This document discusses advancing women's cancer care in sub-Saharan Africa through public-private partnerships like Pink Ribbon Red Ribbon. It notes that while HIV treatment is saving women's lives, many are still dying of cervical cancer. Pink Ribbon Red Ribbon works in 5 countries to increase screening, vaccination, and treatment to reduce cervical and breast cancer deaths by 25% through partnerships across sectors. The challenges of limited advanced cancer care and lack of awareness and access are discussed. Improving prevention, innovative solutions, integrated services, and decentralized cancer centers are keys to helping more women like Evelyn survive cancer.
Prevention and early detection of Prostate Cancer: a global view Vitaly Smelov, International Agency for Research on Cancer (IARC), World Health Organisation (WHO)
Cancer genetic testing and risk assessment overview.
This slide deck was the basis of a presentation to nurse practitioners and genetic counselors who are actively identifying and managing women at high risk of breast and ovarian cancer.
As part of the 4th Annual Early Age Onset CRC Summit theNational Colorectal Cancer Roundtable (NCCRT) Family History and Early Onset Task Group hosted a Special Symposium focused on the importance of Family Health History for colorectal cancer, including advanced adenomas, and its importance in preventing colorectal cancer. The Symposium included presentations on the current challenges and opportunities surrounding ascertainment and documentation of actionable family health history information in primary care.
The utility-visual-inspection-with-acetic-acid-cervical-cancer-screening-ecoa...Amarlasreeja
Cervical cancer is potentially preventable but still remains a leading cause of cancer mortality in in developing countries like Nigeria. Cytology-based screening programmers are difficult to maintain in these countries.
Prevention and early detection of Prostate Cancer: a global view Vitaly Smelov, International Agency for Research on Cancer (IARC), World Health Organisation (WHO)
Cancer genetic testing and risk assessment overview.
This slide deck was the basis of a presentation to nurse practitioners and genetic counselors who are actively identifying and managing women at high risk of breast and ovarian cancer.
As part of the 4th Annual Early Age Onset CRC Summit theNational Colorectal Cancer Roundtable (NCCRT) Family History and Early Onset Task Group hosted a Special Symposium focused on the importance of Family Health History for colorectal cancer, including advanced adenomas, and its importance in preventing colorectal cancer. The Symposium included presentations on the current challenges and opportunities surrounding ascertainment and documentation of actionable family health history information in primary care.
The utility-visual-inspection-with-acetic-acid-cervical-cancer-screening-ecoa...Amarlasreeja
Cervical cancer is potentially preventable but still remains a leading cause of cancer mortality in in developing countries like Nigeria. Cytology-based screening programmers are difficult to maintain in these countries.
No one could have predicted the widespread impact it would have when the then National Cancer Association was established in 1931. Today, the Cancer Association of South Africa (CANSA) plays a leading role in cancer research and cancer control policy development, as well as providing care, support and education to South Africans affected by the dreaded disease.
Read more: http://www.cansa.org.za/celebrating-85-years-of-working-towards-a-world-without-cancer/
Sharad Ghamande, MD, FACOG
Professor and Director of Gynecologic Oncology
Augusta University Cancer Center
Presentation to the Georgia Senate Women's Adequate Healthcare Study Committee
www.gacommissiononwomen.org
Thomas Welty, MD, Associate Director of the Cameroon Baptist Convention Health Services discusses innovative approaches and partnerships to improve Maternal and Child Health in Cameroon a the CCIH 2018 conference.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Report Back from SGO 2023: What’s New in Cervical Cancer?bkling
Curious about what’s new in cervical cancer research? Join Dr. Evelyn Cantillo, gynecologic oncologist at Weill Cornell Medicine, as she shares the latest updates from the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer. Dr. Cantillo will also highlight what the research presented at the conference means for you and answer your questions about the new developments.
Global Health Catalyst Cancer Summit at Harvard V7
1. :
Global Health Catalyst Cancer Summit @Harvard Medical School
Public-Private Partnerships: Advancing Women’s Cancer Care in sub-Saharan Africa
Doyin Oluwole, MD. MRCP, FRCP, FWACP
Executive Director, Pink Ribbon Red Ribbon
2. Total: 35.0 million [33.2 million – 37.2 million]
Middle East & North Africa
230 000
[160 000 – 330 000]
Sub-Saharan Africa
24.7 million
[23.5 million – 26.1 million]
Eastern Europe &
Central Asia
1.1 million
[980 000– 1.3 million]
Asia and the Pacific
4.8 million
[4.1 million – 5.5 million]
North America and Western and Central Europe
2.3 million
[2.0 million – 3.0 million]
Latin America
1.6 million
[1.4 million – 2.1 million]
Caribbean
250 000
[230 000 – 280 000]
The Challenge: HIV/AIDS
Adults and Children Estimated to be Living with HIV I 2013
3. The Challenge:
Women are now surviving a diagnosis
of HIV because of anti-retroviral drugs,
but dying of a preventable disease –
cervical cancer.
The Opportunity:
Antiretroviral Treatment and the Lazarus Effect
4. The Challenge: Inequity of Cervical Cancer
85% of 528,000 cervical cancer cases per year
occur in the developing world.
5. It’s not acceptable to
save a woman’s life from
HIV/AIDS and watch her
die from cervical cancer.
-PRESIDENT GEORGE W. BUSH
6. Pink Ribbon Red Ribbon
Zambia: 2011| Botswana: 2012|Tanzania: 2013| Ethiopia: 2015| Namibia: 2015
The leading public-private
partnership aimed at
catalyzing the global
community to reduce
deaths from cervical and
breast cancer in sub-
Saharan Africa and Latin
America through: raising
awareness of these
diseases and increasing
access to quality services
to detect and treat them.
A global catalyst Launched: 2011
Founded by the George
W. Bush Institute, the
United States
Government through
the U.S. Emergency
Plan for AIDS Relief
(PEPFAR), Susan G.
Komen, and the Joint
United Nations
Programme on
HIV/AIDS (UNAIDS).
Work in 5 countries
With plans to expand to
Latin America
Namibia Botswana
Zambia
Tanzania
Ethiopia
7. Primary
Prevention
HPV
vaccine
Secondary
Prevention/S
creening
CBE
VIA
HPV
Cytology
Treat (if
abnormal):
Cryotherapy
Refer
Referral
Colposcopy
LEEP
Biopsy
Labs
Cancer Rx
Surgery
Chemo
Radiation
Palliative
Care
Awareness Raising/Community Education
Continuum of Cancer Control and Care
8. Transitioning programs to national governments with an enabling policy environment and
budget to sustain them.
Goals
deaths from
cervical cancer by
25% among
women screened
and treated in
partner
countries.
Achieve at least
80%
coverage of
vaccination against
HPV.
Screen at least
80%
of the appropriate
target populations for
pre-invasive cervical
cancer, and treat
those found with
lesions.
awareness
reduce stigma
about breast and cervical
cancer, and promote the early
detection of the disease.
Create and test innovative approaches to sustainability,
financing, service-delivery, and laboratory and data systems that
can be scaled-up and used globally.
9. PINK RIBBON RED RIBBON
PARTNERS
NEW PARTNERS:
• AIRBORNE LIFELINE
FOUNDATION
• INTERNATIONAL ATOMIC
ENERGY AGENCY (IAEA)
• VODACOM FOUNDATION
• GENERAL ELECTRIC
Partner
Countries
10. Partners’ Roles---The Continuum of Cancer Care
Primary
Prevention
Secondary
Prevention:
Screening
Secondary
Prevention:
Treatment
Referral
Diagnosis:
Treatment
Palliative Care
& Hospice
Data/Registry
12. A Diagonal Program
PRRR mobilizes resources from governments, foundations, corporate and philanthropic
organizations and individuals
Starting from the HIV platform, integrates women’s cancers;
Strengthens countries’ capacities to deliver comprehensive
cancer control & address other chronic diseases;
PRRR activities are aligned with country plans & responsive
to the national needs & priorities: 3 Tiers of engagement;
Partners fill countries’ prioritized gaps to ensure
comprehensive service delivery;
Commitments are publicly made & periodically reported on
to promote accountability.
13. Pink Ribbon Red Ribbon Strategies
EDUCATION
AWARENESS
SCREENINGSVACCINATION
ACCESS
TREATMENT SKILLS BUILDING
&
EQUIPMENT
15. Results from Zambia (since 2011), Botswana (since 2012) and Tanzania (since 2013)
Partnerships + Access = Results
HPV Vaccine
42,045
Number of girls
who have received
all three
doses of HPV
vaccine
Basic
Cervical
Screening
153,670
Number of
women screened
for cervical
cancer.
Basic
Treatment
14,089
Number of
women treated
with cryotherapy
or LEEP.
Breast
Cancer
Screening
5,228
Number of
women screened
for breast cancer
in Tanzania.
16. Challenges: Cancer Care
• 33,991 women are diagnosed with
cervical and breast cancer annually in the
five Pink Ribbon Red Ribbon-supported
countries;
• This number is under-reported, as many
do not seek care in hospitals;
• Unfortunately data on the percentage
that receive advanced treatment is
unknown;
• A significant percentage of women
present with late-stage disease not
amenable to treatment.
17. 5,000
new cancer patients each year
2,500
are breast and cervical cancer patients
Ocean Road Cancer Institute
2,000
come from outside of Dar es Salaam
500
need a place to stay during cancer treatment
CaseStudy:Tanzania
18. The Story of Evelyn
https://www.youtube.com/watch?v=gUbxGwbANgU
19. • Information and knowledge of the disease
• HPV vaccination
• Screening, early detection and treatment services
• Funds to pay for health care services
• Advanced cancer care close to home—
geographic access
• Strong healthcare system
Evelyn died because she lacked access to:
21. The Future
Fewer Evelyns!
Prevention: one-dose HPV vaccine
Innovative solutions to reach more women more quickly
o HPV DNA testing will reduce number of women needing VIA
o Cryopen: gasless cryotherapy
o Mobile services models to augment fixed facilities
o Improved data management & tracking systems: IT and mobile
devices
Integration of screening and treatment services with existing health
services such as family planning and post-natal care
Decentralized, functional cancer centers to provide quality care as near
to the population as possible: human capital; equipment; maintenance
and standards of practice.
22. CONNECT WITH PINK RIBBON RED RIBBON
Doyin Oluwole
Executive Director
214.751.4318
doluwole@bushcenter.org
www.pinkribbonredribbon.org
@pinkredribbon
Editor's Notes
Specifically Pink Ribbon Red Ribbon’s goals are to:
-reduce deaths from cervical cancer by 25% among women screened and treated in the countries where we work.
-screen at least 80% of the appropriate target populations for pre-invasive cervical cancer.
-increase awareness and reduce stigma about breast and cervical cancer.
-achieve at least 80% coverage of vaccination against HPV.
-create and test innovative approaches to sustainability, financing, service delivery and laboratory and data systems.